New FOAs From SAMHSA And NIH + Updated CMS Opioid Prescribing Mapping Tool

Below are reminders of some recent funding opportunity announcements from the Substance Abuse & Mental Health Services Administration (SAMHSA). You can refer to the updated Medicare Part D Opioid Prescribing Mapping tool from Centers for Medicare & Medicaid Services (CMS) as a resource.

Be sure to check out our newest SAE CAREs Podcast: From the Lens of a SAMHSA Grant Reviewer! We discuss how SAMHSA applications are actually reviewed, as well as how to increase an applicant’s chance of getting a SAMHSA award.

Offender Reentry Program

  • Deadline: Applications due January 26, 2018.
  • Award: Awards of up to $425,000 per year for up to five years.
  • Eligibility: Domestic public and private nonprofit entities.
  • Summary: The purpose of this program is to expand substance use disorder (SUD) treatment and related recovery and reentry services to sentenced adult offenders/ex-offenders with a SUD and/or co-occurring substance use and mental disorders, who are returning to their families and community from incarceration in state and local facilities including prisons, jails, or detention centers.

Family Treatment Drug Courts

  • Deadline: Applications due January 16, 2018.
  • Award: Awards of up to $425,000 per year for up to five years.
  • Eligibility: State governments; the District of Columbia, Guam, the Commonwealth of Puerto Rico, the Northern Mariana Islands, the Virgin Islands, American Samoa, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau are also eligible to apply; governmental units within political subdivisions of a state, such as a county, city or town; federally recognized American Indian/Alaska Native (AI/AN) tribes, tribal organizations, Urban Indian Organizations, and consortia of tribes or tribal organizations.
  • Summary: The purpose of this program is to expand substance use disorder (SUD) treatment services in existing family treatment drug courts, which use the family treatment drug court model in order to provide alcohol and drug treatment to parents with a SUD and/or co-occurring SUD and mental disorders who have had a dependency petition filed against them or are at risk of such filing. Services must address the needs of the family as a whole and include direct service provision to children (18 and under) of individuals served by this project.

NIH Clinical Trials or Observational Studies of Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants

  • Deadline: Applications due January 18, 2018.
  • Award: NCCIH intends to commit $1,500,000 (total costs) in FY 2018 to this project. Direct costs will vary with the scope of the project. Support for the R21 phase may not exceed $200,000 direct costs. The R33 phase direct costs must not exceed $500,000 per year. The project period is limited to 1 year for the R21 phase and to 2 years for the R33 phase, and the maximum project period must coincide with period of SAMHSA funding for TI-17-014.
  • Eligibility: Higher Education Institutions; Nonprofits with or without 501(c)(3) IRS Status; For-Profit Organizations (Including Small Businesses); State, County, City, Township, and Special District Governments; Indian/Native American Tribal Governments and Organizations (Federally Recognized and Not); U.S. Territory or Possession; Independent School Districts; Public Housing Authorities/Indian Housing Authorities; Faith-based or Community-based Organizations; and Regional Organizations.
  • Summary: The purpose of this FOA is to solicit applications proposing to test approaches using behavioral interventions for primary or secondary prevention of opioid use disorder (OUD) or as an adjunct to medication assisted treatment (MAT) for OUD in general healthcare in the context of states’ plans for use of the funds authorized under the 21st Century Cures Act. A primary goal of this FOA is to encourage studies evaluating whether select behavioral interventions may improve uptake or adherence to MAT, relapse prevention, or prevention of OUD in at risk people.

Opioid State Targeted Response Technical Assistance

  • Deadline: Applications due December 26, 2018.
  • Award: Awards of up to $12,000,000 per year for up to two years.
  • Eligibility: Domestic public and private nonprofit entities.
  • Summary: The purpose of this program is to identify local physicians, other clinicians, and other providers, for example, advance practice nurses, physician assistants, peers and other healthcare professionals with expertise in treatment and in recovery services for opioid use disorders (OUDs). Based on a state, territory, or tribal nation’s assessed need, these providers will serve as the primary providers of federally supported TA for the program’s successful implementation. The goal of this TA is to ensure the provision of evidence-based prevention, treatment, and recovery support programs/services across the Opioid STR program.